KATHERINE RINEHART: Open Payments
NPI 1326628686 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 19 payments from 9 companies in 2025. Trend: 2023 $25 · 2024 $16 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $111 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| QOL Medical, LLC | 2 | $55 |
| GENZYME CORPORATION | 2 | $44 |
| BSN Medical Inc | 1 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| EVOKE PHARMA, INC. | 1 | $25 |
| Ardelyx, Inc. | 1 | $24 |
| Celltrion USA Inc. | 1 | $17 |
Products named: DUPIXENT, OMVOH, Sucraid, CUTIMED, XIFAXAN, GIMOTI, IBSRELA, VEGZELMA.
Industry payments across AL — which companies pay providers there.
